Alzheimer's disease (AD) is a neurodegenerative disorder characterized by pathological deposits of b-amyloid (Ab) in senile plaques, intracellular neurofibrillary tangles (NFTs) comprising hyperphosphorylated aggregated tau, synaptic dysfunction and neuronal death. Substantial evidence indicates that disrupted neuronal calcium homeostasis is an early event in AD that could mediate synaptic dysfunction and neuronal toxicity. Sodium calcium exchangers (NCXs) play important roles in regulating intracellular calcium, and accumulating data suggests that reduced NCX function, following aberrant proteolytic cleavage of these exchangers, may contribute to neurodegeneration. Here, we show that elevated calpain, but not caspase-3, activity is a prominent feature of AD brain. In addition, we observe increased calpain-mediated cleavage of NCX3, but not a related family member NCX1, in AD brain relative to unaffected tissue and that from other neurodegenerative conditions. Moreover, the extent of NCX3 proteolysis correlated significantly with amounts of Ab1-42. We also show that exposure of primary cortical neurons to oligomeric Ab1-42 results in calpain-dependent cleavage of NCX3, and we demonstrate that loss of NCX3 function is associated with Ab toxicity. Our findings suggest that Ab mediates calpain cleavage of NCX3 in AD brain and therefore that reduced NCX3 activity could contribute to the sustained increases in intraneuronal calcium concentrations that are associated with synaptic and neuronal dysfunction in AD.
Introduction
Degenerating brain regions in Alzheimer's disease (AD) show deposits of b-amyloid (Ab) in senile plaques and accumulation of hyperphosphorylated tau aggregates in intracellular neurofibrillary tangles (Schellenberg & Montine, 2012) . Substantial evidence indicates that disrupted neuronal Ca 2+ homeostasis in these brain areas is likely an early event in AD pathogenesis that mediates synaptic dysfunction and neuronal toxicity (Small, 2009; Li et al., 2011 (Verkhratsky & Toescu, 2003) . These events may account for alterations in cellular Ca 2+ homeostasis in familial AD. In cellular models of sporadic AD, application of Ab has been shown to cause the formation of Ca
2+
-permeable pores in bilayer membranes (Arispe et al., 1993) or thinning of membranes resulting in increased ion permeability (Kayed et al., 2004) . Many reports also demonstrate that Ab stimulates neuronal Ca 2+ influx through native ion channels and/or receptors (Small, 2009) , and increased Ca 2+ influx via these mechanisms leads to rapid increases in neuronal Ca 2+ content. Recent evidence has suggested that inactivation of plasma membrane ion exchangers may also contribute to sustained neuronal Ca 2+ overload in neurodegenerative conditions by preventing the extrusion of excess cytosolic Ca 2+ (Bano et al., 2005 (Bano et al., , 2007 .
In conditions of high [Ca 2+ ] i , the sodium calcium exchanger (NCX) family members, NCX1, NCX2 and NCX3, activate high-capacity currents to extrude excess Ca 2+ from the cytosol in exchange for Na + ions (Lytton, 2007) . NCX3 is subject to cleavage by the Ca 2+ -activated cysteine protease calpain-1 (Bano et al., 2005 (Bano et al., , 2007 and by caspase-3 (Bano et al., 2007) . Calpain-1-mediated cleavage of NCX3 diminishes NCX3 exchanger activity by preventing the binding of Ca 2+ to the NCX Ca 2+ regulatory domain, a process essential for NCX function (Bano et al., 2005 (Bano et al., , 2007 . In a cell-based model of ischaemia, Bano et al. (2005) found that cleavage of NCX3 by calpain-1 caused the inactivation of NCX3 ionic exchange activity, retention of intracellular Ca 2+ , prolonged calpain activation and resultant neurotoxicity. These effects were reversed by over-expression of the calpain inhibitor, calpastatin. Similar outcomes have also been reported following the treatment of hippocampal neurons with excitotoxic concentrations of glutamate (Brustovetsky et al., 2010) . Increased calpain activity is a prominent feature of postmortem AD brain (Nixon, 2003) , leading to speculation that NCX function may be altered during the development of AD. Application of Ab1-42 to primary neuronal cultures results in the elevation of calpain-1 activity (Town et al., 2002; Noble et al., 2009) , and transgenic mice over-expressing mutant human APP also exhibit increased calpain-1 activity (Vaisid et al., 2007) . Thus, it is possible that Ab-induced increases in calpain activity may modulate NCX3 function in AD. In support of this, Sokolow et al. (2011) demonstrated co-localization of NCX3 and Ab in synaptosome preparations from AD brain and a loss of NCX3 holoprotein in homogenates of parietal cortex in AD.
In this study, we have investigated the possibility that NCX3 function is disrupted in AD as a result of NCX cleavage by calpain. Examination of postmortem human brain showed that elevated calpain-1 activity and reduced activity of the endogenous calpain inhibitor, calpastatin, are closely associated with increased fragmentation of NCX3 in AD brain. This appears to be relatively specific for AD as significantly altered NCX3 cleavage was not observed in brain from other neurodegenerative tauopathies. The other tauopathies examined were frontotemporal dementia with parkinsonism associated with tau mutations on chromosome 17 (FTD), corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP). It is worth noting that CBD and PSP also show significant tau pathology in the frontal cortex in end-stage disease, especially when assessed using biochemical methods (Zhukareva et al., 2006) .
No changes were observed in either the total protein amounts or cleavage of NCX1, another NCX family member, in any neurodegenerative tauopathy brain. This suggests that related proteins do not compensate for NCX3 inactivation in AD. In addition, our data suggest that the over-production of Ab in AD is likely to cause calpain-mediated NCX3 cleavage, because we found a significant positive correlation between Ab amounts and calpain-mediated NCX3 cleavage in AD brain. In primary neural cell cultures, treatment with 10 lM Ab1-42 induced calpain cleavage of NCX3, and this was prevented by treatment with the calpain inhibitor, calpeptin. In addition, suppression of NCX3 expression with antisense oligonucleotides sensitized neurons to normally subtoxic concentrations of Ab1-42.
Results
NCX3 is cleaved by both calpain-1 and caspase-3 in cell models of neurological disease (Bano et al., 2005) . Thus, we first determined the relative activities of these proteases in neurodegenerative disease brain on Western blots. To determine whether any changes detected were specific to AD, we also examined three other tauopathies, PSP, CBD and FTD caused by the intronic tau mutation 10 + 16.
Calpain-1 activity is increased in tauopathy brain
Calpain-1 is an approximately 80-kDa Ca 2+ -activated cysteine protease that is activated by its autolysis into 76-and 58-kDa fragments (Goll et al., 2003) . Blots of postmortem human brain were probed with an antibody that specifically detects the active 76-kDa subunit of calpain-1 (Fig. S1 , Supporting information), revealing a single prominent band of the expected size (Fig. 1A ). Blots were also probed with an antibody to neuron-specific enolase (NSE) for normalization purposes and to control for any loss of neuronal proteins and/or gliosis. This analysis revealed that active calpain-1 is significantly increased in AD cortex (P < 0.001) when compared to controls (Fig. 1B) . In addition, significantly increased amounts of active calpain-1 were also detected in cortex from PSP, CBD and FTD brain (P < 0.05 for all). Blots were also probed with an antibody against calpain-2 that detects calpain-2 holoprotein at 76-80 kDa and active calpain-2 at 58 kDa (Huang et al., 2010) . When standardized against NSE, somewhat elevated amounts of active calpain-2 were detected in AD and FTD brain; however, these differences were not statistically significant (Fig. 1A,C) . Nevertheless, these findings confirm previous data showing that calpain-1 activity is increased in AD brain (Saito et al., 1993) and indicate that increased calpain-1 cleavage to its active form is observed not only in conditions characterized by elevated Ab deposition, but also in a number of other neurodegenerative tauopathies.
Active calpastatin is decreased in neurodegenerative disease brain
An important cellular regulator of calpain activity in the brain is the endogenous calpain-1 and calpain-2 inhibitor, calpastatin (CAST) (Rao et al., 2008) . It has been suggested that reduced CAST amounts and/or activities might contribute to the increased activation of calpain observed in AD brain (Rao et al., 2008) . To examine CAST activity in tauopathy brain, cortical lysates were immunoblotted with a polyclonal antibody directed against human CAST. This antibody detects CAST holoprotein at 110-120 kDa, as well as a number of calpain-cleaved CAST fragments of 37-75 kDa, which, together with the full-length protein, have calpain inhibitory activity. Several inactive CAST fragments (< 25 kDa), generated by the action of caspase-1 and caspase-3 on CAST (Rao et al., 2008) , were also detected by this antibody (Fig. 1A) . Following normalization to NSE, we found no differences in the total amount (intact plus fragments) of CAST between any groups (Fig. 1D) . In contrast, there was a significant decrease in the amount of full-length CAST as a proportion of total CAST in AD brain relative to controls (P < 0.05, Fig. 1E ), with samples from other tauopathies showing a trend towards decreased CAST holoprotein. The amounts of active CAST (holoprotein plus 37-75 kDa fragments) and inactive CAST (fragments < 25 kDa) were then quantified as a proportion of total CAST. We found significant decreases in the amounts of active CAST fragments and corresponding increases in inactive CAST protein, in AD, PSP, CBD and FTD in comparison with control brain (Fig. 1F,G) . These findings support previous results showing reduced CAST activity in AD brain (Nilsson et al., 1990; Nixon, 2003; Rao et al., 2008) and extend this data with the novel finding that CAST activity is decreased in brain from 'pure' tauopathies.
Active caspase-3 is not increased in postmortem neurodegenerative disease brain As caspase-3 can also cleave and inactivate NCX3 (Bano et al., 2007) , we next assessed the activity of this protease in the control and diseased brain samples. Caspase-3 exists as a holoprotein (pro-caspase-3, approximately 32 kDa) with limited enzymatic activity. Caspase-3 is cleaved by caspase-8 and caspase-9 to generate active fragments of approximately 17 and 19 kDa. Western blotting with an antibody that detects active caspase-3 revealed a prominent band of 19 kDa and a relatively weak band at 17 kDa, corresponding to active caspase-3 fragments (Fig. 1A) . Relative to NSE, we found no significant increases in the amounts of cleaved caspase-3 fragments in any of the neurodegenerative conditions investigated when compared to control brain (Fig. 1H ). This finding suggests that caspase-3 activity is not globally increased in neurodegenerative disease cortex, at least not to an extent detectable by immunoblotting. This is consistent with previous reports showing that only 'exceptional' neurons label with antibodies against active caspase-3 in AD brain (Jellinger & Stadelmann, 2000) .
Altered proteolysis of the calpain and caspase-3 substrate, a-spectrin, in neurodegenerative disease brain
To further assess calpain-1 and caspase-3 activities in neurodegenerative disease brain, calpain-1-and caspase-3-mediated cleavage of the cytoskeletal protein a-spectrin was examined. Calpains cleave 240 kDa a-spectrin holoprotein to generate 145-and 150-kDa products, whereas cleavage by caspase-3 results in the production of 120-and 150-kDa fragments (Martin et al., 1995) . When standardized to NSE, there were no significant differences in total a-spectrin amounts (holoprotein and all fragments) between groups ( Fig. 2A,B) . In contrast, when the amount of full-length a-spectrin was quantified as a proportion of total a-spectrin, analysis revealed a loss of the holoprotein in AD (P < 0.05) and CBD (P < 0.005) brain ( Fig. 2A,C) . We also observed a significant increase in Aberrant NCX3 cleavage in AD, J. Atherton et al.
the amount of 140-50 kDa calpain-and caspase-cleaved fragments as a proportion of total a-spectrin in AD (P < 0.01) brain when compared to controls ( Fig. 2A,D) . In contrast, when the 110-to 125-kDa caspasecleaved a-spectrin products were analysed as a proportion of total a-spectrin, a significant increase in the amount of these fragments was found only in CBD brain (P < 0.01) ( Fig. 2A,E) . As there were no significant increases in the amount of the caspase-3-cleaved 110-to 125-kDa fragments in AD brain, this suggests that the accumulation of the 140-to 150-kDa fragments detected in these brains occurs as a result of calpain, rather than caspase, activity. Therefore, these findings appear to support the notion of increased calpain-mediated proteolysis in AD.
NCX3 cleavage by calpain is elevated in AD brain
We next determined the amount of full-length and cleaved NCX3 in postmortem human brain. Western blotting with an antibody previously shown to detect full-length and cleaved NCX3 in cultured neurons (Bano et al., 2005) revealed a band of approximately 110 kDa, which corresponds to the predicted molecular weight of full-length NCX3 (Fig. 3A) . In addition, a single band of approximately 66 kDa was observed, which corresponds to caspase-cleaved NCX3, and a cluster of bands of approximately 60 kDa are calpain-cleaved NCX3 (Bano et al., 2005 (Bano et al., , 2007 . Blots were normalized by probing with an antibody against NSE. Quantification of the total amount of NCX3 (intact plus fragmented) showed that there were no significant differences between any tauopathy and control brain following normalization to NSE (Fig. 3B ). There was, however, a significant decrease in the amount of NCX3 holoprotein in AD brain relative to control ( Fig. 3C , P < 0.005) in agreement with previous studies . This reduction in intact NCX3 appeared to be specific to AD brain because full-length NCX3 was not significantly altered in PSP, CBD or FTD brain. In addition, no significant differences in the amount of caspase-3-cleaved NCX3 fragments were detected in any tauopathy tissue (Fig. 3D ), supporting our earlier findings that there is no global increase in caspase-3 activity in these brains. However, we found a significant increase in the amount of calpain-cleaved NCX3 in AD, but not in any other disease group, when compared to control brain (Fig. 3E) . This is consistent with our finding of decreased intact NCX3 in these samples and our demonstration of elevated calpain-1 activity in AD brain. It is possible that NCX3 cleavage is increased in AD as a result of altered neuronal distribution of active calpain and/or NCX3, as suggested by previous studies . These results indicate that calpain-mediated cleavage of the NCX3 exchanger is a prominent feature of AD brain. Because NCX3 cleavage disrupts the ion exchanger activity of this channel (Bano et al., 2005 (Bano et al., , 2007 , this finding suggests that altered NCX3 function may contribute to the abnormal neuronal regulation of Ca 2+ in AD.
We also assessed the amount of NCX1 in these brain samples to determine whether there are alterations in the amounts or activity of this related ion exchanger in neurodegenerative disease brain, which may indicate compensation for loss of NCX3 function. When Western blots were probed with an antibody that detects NCX1, an immunoreactive band was observed at approximately 120 kDa, corresponding to the predicted molecular weight of full-length NCX1 (Shaikh et al., 2010) as well as cleaved species at 70-80 kDa (Fig. 3A) . Quantification of total NCX1 protein as a proportion of NSE revealed no significant alterations in NCX1 in any of the neurodegenerative disease brains when compared to controls. Moreover, no changes in the amount of full-length NCX1, or calpain-cleaved NCX1 species, were detected in any experimental group in relation to control brain (data not shown). These results indicate that loss of NCX3 function does not result in an upregulation of the related family member, NCX1.
Ab1-42 burden correlates with NCX3 cleavage in AD brain
Because Ab is known to activate calpain-1 in neurons, we sought to determine whether increased calpain-mediated NCX3 cleavage is associated with elevated Ab amounts in postmortem AD brain. Ab ELISAs were used to determine total amounts of Ab1-40 and Ab1-42, and the ratio of Ab1-42/Ab1-40 in control and AD brain (Fig. 4A-C) . These data were then correlated with the amounts of active calpain-1 proteins and calpain-cleaved NCX3 fragments (Fig. 4D-I ). These analyses revealed that Ab1-42 amounts significantly correlate with calpain activity (Fig. 3E , P < 0.05) and the presence of calpain-cleaved NCX3 protein fragments (Fig. 3H , P < 0.005) in control and AD brain. We also found a strong correlation between calpain-1 activity and the amounts of calpain-cleaved NCX3 fragments, as would be expected (Fig. 4J) . These data support the hypothesis that calpain-mediated NCX3 cleavage is driven by altered Ab production in AD brain. Unfortunately, due to the small number of samples available, it was not possible to correlate calpain-1 activity and NCX3 cleavage in brain from other tauopathies.
Ab induces calpain-dependent NCX3 cleavage
To determine whether calpain-mediated cleavage of NCX3 is causally related to elevated Ab amounts in AD, we measured NCX3 cleavage following application of 10 lM soluble oligomeric Ab1-42 to primary cortical neuronal cultures for 48 h. We have previously shown that this treatment results in neurotoxicity (Noble et al., 2009; Garwood et al., 2011) . Western blots of cell lysates revealed increased amounts of active calpain-1 (76 kDa) and caspase-3 (19 kDa) in neurons exposed to Ab relative to vehicle-treated cells (Fig. 5A-C) . Total NCX3 protein amounts were unchanged by Ab treatment (Fig. 5A) , although there was a small, but nonsignificant reduction in the amount of full-length NCX3 present in Ab-treated cells following standardization to b-actin amounts (data not shown). In contrast, Ab treatment increased the generation of calpain-cleaved (66 kDa) fragments of NCX3 ( Fig. 5D , P < 0.05), and this was prevented when neurons were pretreated for 3 h with the calpain inhibitor, calpeptin (5 lM, Fig. 5A,D) , which also lowered Ab-induced increases in calpain activity (Fig. 5B) . The generation of caspase-cleaved NCX3 fragments were not affected by Ab treatment (Fig. 5A,E) . These findings show that Ab1-42 induces calpain-dependent cleavage of NCX3 in primary cortical neurons, and therefore, elevated Ab content may account for the increased NCX3 cleavage we observed in AD brain relative to controls. To determine whether calpain-mediated NCX3 cleavage is associated with Ab-induced neurotoxicity, primary cortical cultures were pretreated with 5 lM calpeptin prior to application of 10 lM soluble oligomeric Ab, and cell death was assessed by live/dead assay ( Fig. 5F ) and LDH release (Fig. 5G) . Ab treatment for 48 h resulted in a statistically significant increase in neuronal cell death, as observed by the degeneration of bIIItubulin-labelled primary neurons (green), increased incorporation of dead cell dye (red) and the appearance of fragmented, condensed nuclei (blue). The extent of cell death was reduced upon pretreatment of cultures with calpeptin (Fig. 5F ). These results were confirmed by the measurement of lactate dehydrogenase (LDH) release (Fig. 5G) . These findings show that elevated calpain activity is closely associated with Ab-induced neurotoxicity and suggest that Ab-induced calpain-mediated NCX3 cleavage may contribute to neuronal loss in AD, perhaps by preventing the extrusion of excess intraneuronal Ca 2+ .
NCX3 expression mediates Ab-induced neurotoxicity
To further investigate the role of NCX3 in Ab-mediated neurotoxicity, rat primary cortical cultures were treated with phosphorothioated sense or antisense oligonucleotides specific for rat NCX3, as previously described (Iwamoto & Kita, 2006 in an approximately 38.5 AE 12.6% reduction in NCX3 protein amounts (Fig. 6A ), in line with previous observations in primary neurons (RanciatMcComb et al., 2000) . The amounts of NCX3 fragments were less affected by exposure to antisense oligonucleotides, suggesting that the turnover rate of cleaved NCX3 may be slower than that of the full-length protein. Sense oligonucleotides to NCX3 had no effect on NCX3 levels (Fig. 6A ). Cultures were also treated with 1 lM Ab for a further 16 h. This treatment alone had no significant effect on cell death in comparison with vehicle-treated cells (Fig. 6B) . In contrast, application of 1 lM Ab for 16 h caused a significant increase in cell death in cells treated with antisense NCX3 oligonucleotides in comparison with cells treated with vehicle or sense NCX3 oligonucleotides (P < 0.05, Fig. 6B ).
The relatively modest extent of the enhanced sensitivity to Ab toxicity may be indicative of compensation for NCX3 loss of function in these cells, as has been previously demonstrated in rat cerebellar granule cells (Bano et al., 2007) . Nevertheless, these results indicate that reduced expression of functional NCX3 exchangers can sensitize cultured neurons to Ab. 
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Discussion
Altered cellular Ca 2+ homeostasis is an early and prominent feature of AD that likely accelerates disease progression (Small, 2009) . In cell models of AD, Ab-induced neuronal Ca 2+ influx through native ion channels and/or plasma membrane pores leads to synaptic deficits, altered long term potentiation, learning and memory impairments, and neurotoxicity (Smith et al., 2005) . Similarly, altered cellular Ca 2+ regulation is apparent in the vicinity of amyloid plaques in transgenic mice expressing mutant human APP (Kuchibhotla et al., 2008 -dependent activation of the calpain family of proteases. Calpains mediate an array of disease-associated events including aberrant amyloid precursor protein processing (Mathews et al., 2002) , generation of potentially toxic tau fragments (Nicholson et al., 2011) , activation of key tau protein kinases including cyclin-dependent kinase 5 and glycogen synthase kinase 3 (Town et al., 2002; Goni-Oliver et al., 2007) , processing of dynamin 1, a protein critically involved in memory formation (Kelly et al., 2005) , Ab-induced synaptic dysfunction (Trinchese et al., 2008) and LTP impairment (Li et al., 2011) . These data thus suggest a key role for calpains as mediators of the synaptotoxic and neurotoxic events that occur downstream of Ab-induced increases in AD.
In addition, calpain activation has also been demonstrated to influence the cellular mechanisms that regulate Ca 2+ efflux. Several studies have shown that calpain cleaves and inactivates NCX3 ion exchangers, preventing the extrusion of excess neuronal Ca 2+ (Bano et al., 2005 (Bano et al., , 2007 Brustovetsky et al., 2010) . Here, we have demonstrated that Ab induces calpain-mediated NCX3 cleavage in primary cortical cultures, suggesting that NCX3 cleavage may perhaps contribute to sustained and neurotoxic increases in cellular Ca 2+ in AD. In support of this idea, we show that inhibition of calpain activity ameliorates Ab-induced neuronal loss and that suppressing NCX3 expression with antisense oligonucleotides sensitizes neurons to normally subtoxic doses of Ab. We also observe elevated calpain activity and NCX3 cleavage in postmortem AD brain. Whilst the total amount of NCX3 protein is unchanged, NCX3 truncation was associated with loss of NCX3 holoprotein, supporting previous findings of decreased full-length NCX3, but not NCX1 or NCX2, in parietal cortex or synaptosome preparations from a relatively small number of AD cases . Moreover, the increased proteolysis of NCX3 that we observed showed significant positive correlation with amounts of Ab1-42 in frontal cortex. Because significantly increased NCX3 cleavage was detected only in AD, but not other tauopathy brain, this raises the possibility that analysis of NCX3 fragments may have utility as a biomarker for AD. It is of interest that increased abundance of NCX3 fragments was only observed in AD brain despite other tauopathies also showing elevated calpain activity. It has previously been shown that tau can bind to EF hand domain-containing proteins (Vega et al., 2008) . It is therefore possible that NCX3 fragments may bind PHF tau, a conformation of tau that is found in AD and not other tauopathy brain, and thereby become sequestered into insoluble tau aggregates that are not easily degraded, thereby leading to an accumulation of these fragments in postmortem AD brain. A similar mechanism may explain the increase in calpain-cleaved a-spectrin fragments that were found to accumulate in AD tissue. Indeed, cleaved a-spectrin fragments have previously been identified in affected neurons in AD brain (Ayala-Grosso et al., 2006) . Accumulating evidence shows that Ab induces disruptions in cellular Ca 2+ homeostasis that are particularly detrimental to synaptic function in AD . NCX3 is expressed in subpopulations of neurons, where it localizes predominantly to dendrites and distal astrocyte processes that contact excitatory synapses (Minelli et al., 2007) . This positioning suggests that NCX3 may play a key role in regulating Ca 2+ currents during synaptic activity. Furthermore, NCX3 buffering of astrocytic Na + could further impact on synaptic function by regulating the activity of Na+-dependent glutamate transporters that are critical for the clearance of extracellular glutamate during synaptic activity (Minelli et al., 2007) . Because healthy synaptic transmission is essential for normal learning and memory (DeKosky & Scheff, 1990; Sze et al., 1997) , this implies that NCX3-mediated sustained elevations in neuronal Ca 2+ may contribute to the synaptic dysfunction and cognitive deficits associated with Ab in AD. Indeed, NCX3 has been shown to play a crucial role in regulating LTP, spatial learning and memory. Higher basal [Ca 2+ ] i , due to delayed Ca 2+ clearance after stimulation of neuronal activity, impaired synaptic transmission and reduced performance in spatial learning and memory tasks have all been observed in NCX3 knockout mice (Molinaro et al., 2011) , a situation analogous to proteolytic inactivation of NCX3. These findings suggest therefore that targeting aberrant NCX3 cleavage by calpain may have therapeutic potential for the treatment for Alzheimer's disease.
Experimental procedures Postmortem human brain
Frozen postmortem human frontal cortex (Table 1) ) in ice-cold lysis buffer, 50 mM Tris-buffered saline, 0.1% (w/v) Triton X-100, 10 mM sodium fluoride, 1 mM sodium orthovanadate, 2 mM ethylene glycol tetraacetic acid, 1 mM phenylmethylsulfonyl fluoride and Complete TM protease inhibitor (Roche), pH 7.4, using a mechanical homogenizer. Following centrifugation of homogenates at 25 000 g(av) for 20 min at 4°C, the supernatants were collected, and protein concentrations were measured using a BCA protein assay kit (Pierce Endogen, Rockford, IL, USA). Samples were standardized to equal protein concentration before being analysed by Western blotting.
Primary cortical cell culture
Primary cortical neuronal cultures were prepared from embryonic day 18 (E18) rat embryos as described previously (Pooler et al., 2013) . Cultures are primarily neuronal with approximately 4% astrocytes and negligible numbers of oligodendrocytes and microglia (Garwood et al., 2011) . Cultures were treated with 10 lM soluble oligomeric Ab1-42 (California Peptide Co., Napa, CA, USA). To inhibit calpain activity, cells were treated with 5 lM calpeptin (EMD Millipore, Billerica, MA, USA) or vehicle for 24 h prior to addition of Ab. Ab1-42 was prepared according to the method described in Garwood et al. (2011) , which generates predominantly soluble oligomeric species of Ab. After treatment, culture medium was removed and cells were washed in phosphate-buffered saline (PBS), lysed in ice-cold lysis buffer and centrifuged at 16 000 g(av) for 20 min at 4°C. The protein concentration of supernatants was measured using a BCA protein assay kit, as described above, and protein concentrations were standardized prior to analysis.
Treatment of primary cortical cultures with oligodeoxynucleotides
Primary cortical cultures (4 DIV) were treated with antisense and sense phosphorothioate oligodeoxynucleotides, specific for rat NCX3 (Iwamoto & Kita, 2006) . The 5′-3′ sequences are as follows: NCX3 antisense: GCCATACACAAGAG; NCX3 sense: CTCTTGTGTATGGC. Cells were incubated with oligodeoxynucleotides (5 lM) and Lipofectamine 2000 (Invitrogen Life Technologies, Paisley, UK), according to the manufacturer's protocol. Twenty-four hours after the application of oligonucleotides, neurons were treated with vehicle or subtoxic (1 lM) concentrations of oligomeric Ab1-42 for a further 16 h. Table 1 Characteristics of postmortem brain samples. Frontal cortex was obtained from postmortem control brains (CTRL), those with Braak stage IV-VI Alzheimer's disease (AD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and frontotemporal dementia with parkinsonism associated with the 10 + 16 tau mutation on chromosome 17 (FTD). Postmortem delay (PMD), age and sex were balanced between groups as far as possible 
Gel electrophoresis and Western blotting
Five to ten microgram protein was loaded onto 10% (w/v) SDSpolyacrylamide gels. Separated proteins were blotted onto nitrocellulose membranes (Whatman, Maidstone, UK) and blocked with 5% (w/v) nonfat milk/0.05% (v/v) Tween 20 in PBS for 1 h. After blocking, membranes were incubated overnight at 4°C in blocking solution containing primary antibody. Blots were washed and incubated with the appropriate fluorophore-conjugated secondary antibodies for 1 h at ambient temperature. Proteins were visualized and quantified using an Odyssey Infrared Imaging system (Li-Cor Biosciences, Cambridge, UK). Human postmortem brain samples were run on multiple gels, each of which contained a standard control sample to enable comparison of samples across gels. Statistical analysis was performed following standardization of specific protein amounts in each sample against NSE, used as a loading control. White lines separating lanes in some immunoblots indicate removal of portions of the blots for clarity and/or splicing together of distinct blots.
Antibodies
The following primary antibodies were used for Western blotting: calpain-1 large active subunit (No. 2556, rabbit IgG; Cell Signalling Ltd, Beverly, MA, USA); calpain-2 (AB81023, rabbit IgG; EMD Millipore, MA, USA); calpastatin (CAST, #4146, rabbit IgG; Cell Signalling Ltd.); cleaved (active) caspase-3 (Asp175, rabbit IgG; Cell Signaling Ltd.); neuronspecific enolase (BBS/NC/VI-H14, mouse IgF; DAKO Ltd, Ely, UK); b-actin (clone AC-15, mouse IgG; Abcam, Cambridge, UK). NCX3 and NCX1 antibodies were kindly provided by Professor Kenneth Phillipson (UCLA) (Porzig et al., 1993; Thurneysen et al., 2002) .
Cell death assays
Cytotoxicity was evaluated by measuring lactate dehydrogenase (LDH) in culture medium using Cytotox 96 assay kits (Promega, Madison, WI, USA) according to the manufacturer's directions. After collection of medium, the remaining cells were lysed in 0.9% (w/v) Triton X-100, and LDH content in medium and lysed cells was measured to determine total LDH content. Optical density was measured at 492 nm (Wallac 1420 Victor 3 plate reader; Perkin-Elmer, Waltham, MA, USA). LDH release from cells was calculated as a percentage of total LDH in each sample. Cell death was confirmed using a live/dead fixable cell stain (Invitrogen, Paisley, UK), performed according to the manufacturer's instructions. Following uptake of the amine-reactive fluorescent dye, cells were washed, immunolabelled with an antibody against bIII-tubulin, and nuclei were labelled with 1 lg mL À1 Hoechst-33342 as described previously (Garwood et al., 2011) .
Ab1-40 and Ab1-42 ELISA
Ab1-40 and Ab1-42 in human brain samples were quantified using ELISA kits from Invitrogen (Ab40 ELISA KHB3481; Ab1-42 ELISA KHB3442) as we have previously described (Vagnoni et al., 2012) .
Statistical analysis
Normalcy of data was first established using D'Agostino and Pearson omnibus normality tests and was then analysed by parametric one-way analysis of variance followed by Newman-Keuls post hoc tests (Graphpad Prism v5.0; La Jolla, CA, USA). Differences were considered statistically significant when P < 0.05. Differences in the amount of Ab in control and AD human brain were assessed using two-tailed student ttests. These data were correlated with active calpain-1-and calpaincleaved NCX3 protein amounts using parametric two-tailed Pearson tests.
